CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(1.19%)
USD 0.01
(1.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.47 Million USD | 24.7% |
| 2022 | -17.89 Million USD | -14.43% |
| 2021 | -15.64 Million USD | -176.92% |
| 2020 | -5.64 Million USD | 72.93% |
| 2019 | -20.86 Million USD | -138.61% |
| 2018 | -8.74 Million USD | -2442.67% |
| 2017 | -343.88 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.84 Million USD | 11.74% |
| 2024 Q1 | -2.09 Million USD | -44.06% |
| 2023 Q4 | -1.45 Million USD | 58.95% |
| 2023 FY | -13.47 Million USD | 24.7% |
| 2023 Q3 | -3.53 Million USD | 3.93% |
| 2023 Q2 | -3.68 Million USD | 23.33% |
| 2023 Q1 | -4.8 Million USD | 14.82% |
| 2022 FY | -17.89 Million USD | -14.43% |
| 2022 Q4 | -5.63 Million USD | -39.08% |
| 2022 Q3 | -4.05 Million USD | 10.32% |
| 2022 Q2 | -4.52 Million USD | -22.84% |
| 2022 Q1 | -3.68 Million USD | 17.5% |
| 2021 Q2 | -4.01 Million USD | -36.12% |
| 2021 FY | -15.64 Million USD | -176.92% |
| 2021 Q1 | -2.94 Million USD | -22.03% |
| 2021 Q4 | -4.46 Million USD | -5.8% |
| 2021 Q3 | -4.21 Million USD | -5.09% |
| 2020 Q4 | -2.41 Million USD | -230.47% |
| 2020 FY | -5.64 Million USD | 72.93% |
| 2020 Q1 | -1.56 Million USD | 92.2% |
| 2020 Q2 | -934.19 Thousand USD | 40.38% |
| 2020 Q3 | -731.07 Thousand USD | 21.74% |
| 2019 Q1 | -280.64 Thousand USD | 90.7% |
| 2019 Q4 | -20.07 Million USD | -8795.17% |
| 2019 Q3 | -225.69 Thousand USD | 23.85% |
| 2019 FY | -20.86 Million USD | -138.61% |
| 2019 Q2 | -296.37 Thousand USD | -5.61% |
| 2018 Q1 | -137.87 Thousand USD | 0.0% |
| 2018 Q3 | -1.56 Million USD | -955.76% |
| 2018 Q2 | -147.97 Thousand USD | -7.33% |
| 2018 FY | -8.74 Million USD | -2442.67% |
| 2018 Q4 | -3.01 Million USD | -93.22% |
| 2017 Q3 | -140.84 Thousand USD | -179.26% |
| 2017 Q2 | -50.43 Thousand USD | 0.0% |
| 2017 FY | -343.88 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BIMI International Medical Inc. | -15.33 Million USD | 12.133% |
| China Jo-Jo Drugstores, Inc. | -3.53 Million USD | -281.306% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 580 Thousand USD | 2423.707% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 431 Thousand USD | 3227.03% |
| Leafly Holdings, Inc. | -7.05 Million USD | -91.143% |
| Leafly Holdings, Inc. | -7.05 Million USD | -91.143% |
| LifeMD, Inc. | -14.48 Million USD | 6.983% |
| LifeMD, Inc. | -14.48 Million USD | 6.983% |
| TRxADE HEALTH, Inc. | -7.26 Million USD | -85.553% |
| PetMed Express, Inc. | -8.16 Million USD | -65.125% |
| Walgreens Boots Alliance, Inc. | -14.07 Billion USD | 99.904% |